The Sex-Specific Impact of the FORTA (Fit-fOR-The-Aged) List on Medication Quality and Clinical Endpoints in Older Hospitalized Patients: Secondary Analysis of a Randomized Controlled Trial-Reference-Cited by-同舟云学术

The Sex-Specific Impact of the FORTA (Fit-fOR-The-Aged) List on Medication Quality and Clinical Endpoints in Older Hospitalized Patients: Secondary Analysis of a Randomized Controlled Trial

Published:2022-03-16 Issue:2 Volume:9 Page:287-297
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Schmitt Ann-Kathrin,Weiss Christel,Burkhardt Heinrich,Frohnhofen Helmut,Wehling Martin,Pazan Farhad

Funder

Deutsche Forschungsgemeinschaft

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-022-00292-9.pdf

Reference50 articles.

1. Knecht B, Lohmüller J, Telschow C. Ergänzende statistische Übersicht. In: Schwabe U, editor. Arzneiverordnungs-Report 2019. Springer; 2019. p. 1037–102.

2. Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12:443–52. https://doi.org/10.1007/s41999-021-00479-3.

3. Midao L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213–20. https://doi.org/10.1016/j.archger.2018.06.018.

4. Report from the commission to the European parliament, The Council, The European Economic and Social Committee and the Committee of the Regions on the impact of demographic change. Brussels: European Commission; 2020.

5. WHO. World health statistics 2019: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organisation; 2019.